Genetic Technologies
GENE
#10484
Rank
โ‚น0.33 B
Marketcap
โ‚น68.73
Share price
0.00%
Change (1 day)
-66.73%
Change (1 year)

Revenue for Genetic Technologies (GENE)

Revenue in 2008 (TTM): โ‚น0.68 Billion

According to Genetic Technologies's latest financial reports the company's current revenue (TTM ) is โ‚น1.53 Billion. In 2007 the company made a revenue of โ‚น0.65 Billion an increase over the revenue in the year 2006 that were of โ‚น0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genetic Technologies from 2005 to 2008

Annual revenue

Year Revenue Change
2008 (TTM) โ‚น0.68 B5.65%
2007 โ‚น0.65 B110.25%
2006 โ‚น0.31 B-1.15%
2005 โ‚น0.31 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.08 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚น74.14 B 4,725.51%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1.236 T 80,385.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น974.74 B 63,339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น0.62 B-59.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚น2.180 T 141,794.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.929 T 255,617.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น79.67 B 5,085.60%๐Ÿ‡บ๐Ÿ‡ธ USA